Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCUS

Arcus Biosciences Inc

May 01 • 04:00PM ET

25.68

+0.18 0.71 %

Healthcare • Biotechnology • USA • Mid • NYSE

Peers: BMY MRK PFE JNJ GILD ABBV NVS LLY REGN VRTX

| Held by: IJR XBI VTI IWM VB VXF SPSM IBB IWO VBK

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.30	Insider Own	34.04%	Shs Outstand	125.30M	Perf Week	0.71%
Market Cap	3.23B	Forward P/E	-	EPS next Y	-3.33	Insider Trans	-0.87%	Shs Float	82.86M	Perf Month	17.58%
Enterprise Value	2.44B	PEG	-	EPS next Q	-0.88	Inst Own	68.77%	Short Float	13.36%	Perf Quarter	22.05%
Income	-353.00M	P/S	13.06	EPS this Y	-16.35%	Inst Trans	20.93%	Short Ratio	9.00	Perf Half Y	26.56%
Sales	247.00M	P/B	5.10	EPS next Y	13.07%	ROA	-26.01%	Short Interest	11.07M	Perf YTD	7.76%
Book/sh	5.04	P/C	3.29	EPS next 5Y	11.80%	ROE	-63.26%	52W High	28.72 -10.58%	Perf Year	197.91%
Cash/sh	7.81	P/FCF	-	EPS past 3/5Y	3.94% -7.95%	ROIC	-43.26%	52W Low	7.06 263.74%	Perf 3Y	39.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.16% 26.08%	Gross Margin	95.95%	Volatility	4.95% 6.44%	Perf 5Y	-23.91%
Dividend TTM	-	EV/Sales	9.89	EPS Y/Y TTM	-6.50%	Oper. Margin	-156.28%	ATR (14)	1.50	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.36	Sales Y/Y TTM	-4.26%	Profit Margin	-142.91%	RSI (14)	59.44	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	4.36	EPS Q/Q	12.74%	SMA20	7.20%	Beta	0.87	Target Price	34.00
Payout	-	Debt/Eq	0.31	Sales Q/Q	26.92%	SMA50	13.55%	Rel Volume	0.80	Prev Close	25.50
Employees	601	LT Debt/Eq	0.29	Earnings	May 05 AMC	SMA200	38.28%	Avg Volume	1.23M	Price	25.68
IPO	Mar 15, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.55% -7.59%	Trades		Volume	986,405	Change	0.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)